Skip to main content
. 2022 Oct 8;12(10):2437. doi: 10.3390/diagnostics12102437
BE Barrett esophagus
EAC esophageal adenocarcinoma
HRWLE high-resolution white-light endoscopy
SP the Seattle protocol
CLE confocal laser endomicroscopy
AFI autofluorescence imaging
OCT optical coherence tomography
AUC an area under the receiving operator characteristics curve
FISH fluorescence in situ hybridization
CAD computer-assisted diagnosis
VLE volumetric laser endomicroscopy
VLEL a VLE laser marking system
ROI regions of interest
AI artificial intelligence
IEE image-enhanced endoscopy
NBI narrow band imaging
MNBI high-definition magnification NBI
ETMI endoscopic trimodal imaging
CLE confocal laser endomicroscopy
pCLE the probe-based CLE
eCLE the endoscopy-integrated CLE
NIR near-infrared range
FME fluorescence molecular endoscopy
NPs nanoparticles
WGA wheat germ agglutinin
T/B ratio tumor-to-background ratio
ASYNYDA sequences ASY*-fluorescein isothiocyanate
Hsp-TPP membrane-bound Hsp70-specific contrast agent Tumor-Penetrating peptide
IHC the immunohistochemical study
NDBE non-dysplastic Barrett esophagus
LGD low-grade dysplasia
HGD high-grade dysplasia
EGFR epidermal growth factor receptor
HER2 human epidermal growth factor receptor
NIR-FME wide-field near-infrared FME
VEGFA vascular endothelial growth factor
CXCR4 chemokine receptor 4
PpIX protoporphyrin IX
2NBDG 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4- yl)amino]-2-deoxyglucose
GLUT glucose transporters